Related Experiment Videos
Increase of HLA-"DRw6" in patients with juvenile chronic arthritis
Tissue Antigens
|October 1, 1983
Insights
Juvenile chronic arthritis (JCA) shows increased HLA-B27 in males over 9 years old. DRw6 antigen is frequent across subtypes, with DR3 in males and DR5 in females linked to JCA.
Area of Science:
- Immunogenetics
- Rheumatology
- Pediatric Medicine
Background:
- Juvenile chronic arthritis (JCA) is a heterogeneous autoimmune disease affecting children.
- Genetic factors, particularly Human Leukocyte Antigen (HLA) associations, are implicated in JCA pathogenesis.
- Understanding these associations can provide insights into disease subtypes and risk factors.
Purpose of the Study:
- To investigate the frequency of specific HLA antigens in patients with pauciarticular and polyarticular JCA.
- To identify potential correlations between HLA antigen expression and JCA subtypes, age of onset, and sex.
Main Methods:
- Analysis of HLA antigen frequencies in a cohort of 43 pauciarticular and 26 polyarticular JCA patients.
- Comparison of antigen frequencies based on disease subtype, sex, and age of onset.
Main Results:
- Increased frequency of HLA-B27 (36%) was observed in male JCA patients with disease onset after 9 years of age.
- The DRw6 antigen showed a high frequency (57%) across all JCA subtypes.
- Elevated frequencies of DR3 were noted in male JCA patients (40%), and DR5 in female JCA patients (42%).
Conclusions:
- Specific HLA antigens are associated with different subtypes and demographic factors in juvenile chronic arthritis.
- HLA-B27, DRw6, DR3, and DR5 may serve as potential genetic markers for JCA susceptibility and clinical presentation.
- Further research is warranted to elucidate the functional role of these HLA associations in JCA.
Abstract:
In 43 patients with pauciarticular and 26 patients with polyarticular juvenile chronic arthritis (JCA), an increased frequency was found for HLA-B27 (36%) in male patients with onset of the disease over 9 years of age. The antigen "DRw6" was observed in high frequency (average 57%) in all subtypes of the disease. Indications for increased frequencies were obtained for DR3 in male JCA (40%) and DR5 (42%) in female JCA patients.